Cargando…
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
Duchenne muscular dystrophy (DMD) is a lethal neuromuscular disease caused by mutations in the dystrophin gene (DMD). Previously, we applied CRISPR-Cas9–mediated “single-cut” genome editing to correct diverse genetic mutations in animal models of DMD. However, high doses of adeno-associated virus (A...
Autores principales: | Zhang, Yu, Li, Hui, Min, Yi-Li, Sanchez-Ortiz, Efrain, Huang, Jian, Mireault, Alex A., Shelton, John M., Kim, Jiwoong, Mammen, Pradeep P. A., Bassel-Duby, Rhonda, Olson, Eric N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030925/ https://www.ncbi.nlm.nih.gov/pubmed/32128412 http://dx.doi.org/10.1126/sciadv.aay6812 |
Ejemplares similares
-
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
por: Zhang, Yu, et al.
Publicado: (2021) -
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
por: Min, Yi-Li, et al.
Publicado: (2019) -
A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing
por: Zhang, Yu, et al.
Publicado: (2022) -
In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse
por: Amoasii, Leonela, et al.
Publicado: (2019) -
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
por: Chai, Andreas C., et al.
Publicado: (2023)